Downloads:
196,149
Downloads of v 4.0.3:
3,134
Last Update:
03 Dec 2022
Package Maintainer(s):
Software Author(s):
- University Hospital of Geneva
Tags:
weasis medical viewer imaging dicom floss embeddedWeasis Medical Viewer
This is not the latest version of Weasis Medical Viewer available.
- 1
- 2
- 3
4.0.3 | Updated: 03 Dec 2022
Downloads:
196,149
Downloads of v 4.0.3:
3,134
Maintainer(s):
Software Author(s):
- University Hospital of Geneva
Weasis Medical Viewer 4.0.3
This is not the latest version of Weasis Medical Viewer available.
Legal Disclaimer: Neither this package nor Chocolatey Software, Inc. are affiliated with or endorsed by University Hospital of Geneva. The inclusion of University Hospital of Geneva trademark(s), if any, upon this webpage is solely to identify University Hospital of Geneva goods or services and not for commercial purposes.
- 1
- 2
- 3
All Checks are Passing
3 Passing Tests
Deployment Method: Individual Install, Upgrade, & Uninstall
To install Weasis Medical Viewer, run the following command from the command line or from PowerShell:
To upgrade Weasis Medical Viewer, run the following command from the command line or from PowerShell:
To uninstall Weasis Medical Viewer, run the following command from the command line or from PowerShell:
Deployment Method:
This applies to both open source and commercial editions of Chocolatey.
1. Enter Your Internal Repository Url
(this should look similar to https://community.chocolatey.org/api/v2/)
2. Setup Your Environment
1. Ensure you are set for organizational deployment
Please see the organizational deployment guide
2. Get the package into your environment
Option 1: Cached Package (Unreliable, Requires Internet - Same As Community)-
Open Source or Commercial:
- Proxy Repository - Create a proxy nuget repository on Nexus, Artifactory Pro, or a proxy Chocolatey repository on ProGet. Point your upstream to https://community.chocolatey.org/api/v2/. Packages cache on first access automatically. Make sure your choco clients are using your proxy repository as a source and NOT the default community repository. See source command for more information.
- You can also just download the package and push it to a repository Download
-
Open Source
-
Download the package:
Download - Follow manual internalization instructions
-
-
Package Internalizer (C4B)
-
Run: (additional options)
choco download weasis --internalize --version=4.0.3 --source=https://community.chocolatey.org/api/v2/
-
For package and dependencies run:
choco push --source="'INTERNAL REPO URL'"
- Automate package internalization
-
Run: (additional options)
3. Copy Your Script
choco upgrade weasis -y --source="'INTERNAL REPO URL'" --version="'4.0.3'" [other options]
See options you can pass to upgrade.
See best practices for scripting.
Add this to a PowerShell script or use a Batch script with tools and in places where you are calling directly to Chocolatey. If you are integrating, keep in mind enhanced exit codes.
If you do use a PowerShell script, use the following to ensure bad exit codes are shown as failures:
choco upgrade weasis -y --source="'INTERNAL REPO URL'" --version="'4.0.3'"
$exitCode = $LASTEXITCODE
Write-Verbose "Exit code was $exitCode"
$validExitCodes = @(0, 1605, 1614, 1641, 3010)
if ($validExitCodes -contains $exitCode) {
Exit 0
}
Exit $exitCode
- name: Install weasis
win_chocolatey:
name: weasis
version: '4.0.3'
source: INTERNAL REPO URL
state: present
See docs at https://docs.ansible.com/ansible/latest/modules/win_chocolatey_module.html.
chocolatey_package 'weasis' do
action :install
source 'INTERNAL REPO URL'
version '4.0.3'
end
See docs at https://docs.chef.io/resource_chocolatey_package.html.
cChocoPackageInstaller weasis
{
Name = "weasis"
Version = "4.0.3"
Source = "INTERNAL REPO URL"
}
Requires cChoco DSC Resource. See docs at https://github.com/chocolatey/cChoco.
package { 'weasis':
ensure => '4.0.3',
provider => 'chocolatey',
source => 'INTERNAL REPO URL',
}
Requires Puppet Chocolatey Provider module. See docs at https://forge.puppet.com/puppetlabs/chocolatey.
4. If applicable - Chocolatey configuration/installation
See infrastructure management matrix for Chocolatey configuration elements and examples.
This package was approved as a trusted package on 03 Dec 2022.
Weasis is a multipurpose standalone and web-based DICOM viewer with a highly modular architecture. It is a very popular clinical viewer used in healthcare by hospitals, health networks, multicenter research trials, and patients.
It has been designed to meet several expectations of clinical information systems and their future evolution regarding medical imaging: providing web-based access to radiological images, as well as covering a considerable number of DICOM types and offering multimedia capabilities.
General Features
- Flexible integration to HIS or PHR (see integration documentation)
- Desktop distribution (Windows, Mac OS X, and Linux)
- Web access through weasis protocol
- Embedded DICOM viewer (portable distribution) in CD/DVD or other portable media
- Multi-language support
- Configuration of preferences on server-side and client-side
- API for building custom plug-ins
- DICOM Send (storeSCU and STOW-RS)
- DICOM Query/Retrieve (C-GET, C-MOVE and WADO-URI) and DICOMWeb (QUERY and RETRIEVE)
- Dicomizer module (allow importing standard images and convert them in DICOM)
Viewer Features
- Display all kinds of DICOM files (including multi-frame, enhanced, MPEG-2, MPEG-4, MIME Encapsulation, SR, PR, KOS, AU, RT and ECG)
- Viewer for common image formats (TIFF, BMP, GIF, JPEG, PNG, RAS, HDR, and PNM)
- Image manipulation (pan, zoom, windowing, presets, rotation, flip, scroll, crosshair, filtering...)
- Layouts for comparing series or studies
- Advanced series synchronization options
- Display Presentation States (GSPS) and Key Object Selection
- Create key images (Key Object Selection object) by selection
- Support of Modality LUTs, VOI LUTs, and Presentation LUTs (even non-linear)
- Support of several screens with different calibration, support of HiDPI (High Dots Per Inch) monitors, full-screen mode
- Multiplanar reconstructions and Maximum Intensity Projection
- Display Structured Reports
- Display and search into all DICOM attributes
- Display cross-lines
- Measurement and annotation tools
- Region statistics of pixels (Min, Max, Mean, StDev, Skewness, Kurtosis, Entropy)
- Histogram of modality values
- SUV measurement
- Save measurements and annotations in DICOM PR or XML file
- Import CD/DVD and local DICOM files
- Export DICOM with several options (DICOMDIR, ZIP, ISO image file with Weasis, TIFF, JPEG, PNG...)
- Magnifier glass
- Native and DICOM printing
- Read DICOM image containing float or double data (Parametric Map)
- DICOM ECG Viewer
From: https://raw.githubusercontent.com/nroduit/Weasis/master/LICENSE
===================================
Eclipse Public License - v 2.0
THE ACCOMPANYING PROGRAM IS PROVIDED UNDER THE TERMS OF THIS ECLIPSE
PUBLIC LICENSE ("AGREEMENT"). ANY USE, REPRODUCTION OR DISTRIBUTION
OF THE PROGRAM CONSTITUTES RECIPIENT'S ACCEPTANCE OF THIS AGREEMENT.
1. DEFINITIONS
"Contribution" means:
a) in the case of the initial Contributor, the initial content
Distributed under this Agreement, and
b) in the case of each subsequent Contributor:
i) changes to the Program, and
ii) additions to the Program;
where such changes and/or additions to the Program originate from
and are Distributed by that particular Contributor. A Contribution
"originates" from a Contributor if it was added to the Program by
such Contributor itself or anyone acting on such Contributor's behalf.
Contributions do not include changes or additions to the Program that
are not Modified Works.
"Contributor" means any person or entity that Distributes the Program.
"Licensed Patents" mean patent claims licensable by a Contributor which
are necessarily infringed by the use or sale of its Contribution alone
or when combined with the Program.
"Program" means the Contributions Distributed in accordance with this
Agreement.
"Recipient" means anyone who receives the Program under this Agreement
or any Secondary License (as applicable), including Contributors.
"Derivative Works" shall mean any work, whether in Source Code or other
form, that is based on (or derived from) the Program and for which the
editorial revisions, annotations, elaborations, or other modifications
represent, as a whole, an original work of authorship.
"Modified Works" shall mean any work in Source Code or other form that
results from an addition to, deletion from, or modification of the
contents of the Program, including, for purposes of clarity any new file
in Source Code form that contains any contents of the Program. Modified
Works shall not include works that contain only declarations,
interfaces, types, classes, structures, or files of the Program solely
in each case in order to link to, bind by name, or subclass the Program
or Modified Works thereof.
"Distribute" means the acts of a) distributing or b) making available
in any manner that enables the transfer of a copy.
"Source Code" means the form of a Program preferred for making
modifications, including but not limited to software source code,
documentation source, and configuration files.
"Secondary License" means either the GNU General Public License,
Version 2.0, or any later versions of that license, including any
exceptions or additional permissions as identified by the initial
Contributor.
2. GRANT OF RIGHTS
a) Subject to the terms of this Agreement, each Contributor hereby
grants Recipient a non-exclusive, worldwide, royalty-free copyright
license to reproduce, prepare Derivative Works of, publicly display,
publicly perform, Distribute and sublicense the Contribution of such
Contributor, if any, and such Derivative Works.
b) Subject to the terms of this Agreement, each Contributor hereby
grants Recipient a non-exclusive, worldwide, royalty-free patent
license under Licensed Patents to make, use, sell, offer to sell,
import and otherwise transfer the Contribution of such Contributor,
if any, in Source Code or other form. This patent license shall
apply to the combination of the Contribution and the Program if, at
the time the Contribution is added by the Contributor, such addition
of the Contribution causes such combination to be covered by the
Licensed Patents. The patent license shall not apply to any other
combinations which include the Contribution. No hardware per se is
licensed hereunder.
c) Recipient understands that although each Contributor grants the
licenses to its Contributions set forth herein, no assurances are
provided by any Contributor that the Program does not infringe the
patent or other intellectual property rights of any other entity.
Each Contributor disclaims any liability to Recipient for claims
brought by any other entity based on infringement of intellectual
property rights or otherwise. As a condition to exercising the
rights and licenses granted hereunder, each Recipient hereby
assumes sole responsibility to secure any other intellectual
property rights needed, if any. For example, if a third party
patent license is required to allow Recipient to Distribute the
Program, it is Recipient's responsibility to acquire that license
before distributing the Program.
d) Each Contributor represents that to its knowledge it has
sufficient copyright rights in its Contribution, if any, to grant
the copyright license set forth in this Agreement.
e) Notwithstanding the terms of any Secondary License, no
Contributor makes additional grants to any Recipient (other than
those set forth in this Agreement) as a result of such Recipient's
receipt of the Program under the terms of a Secondary License
(if permitted under the terms of Section 3).
3. REQUIREMENTS
3.1 If a Contributor Distributes the Program in any form, then:
a) the Program must also be made available as Source Code, in
accordance with section 3.2, and the Contributor must accompany
the Program with a statement that the Source Code for the Program
is available under this Agreement, and informs Recipients how to
obtain it in a reasonable manner on or through a medium customarily
used for software exchange; and
b) the Contributor may Distribute the Program under a license
different than this Agreement, provided that such license:
i) effectively disclaims on behalf of all other Contributors all
warranties and conditions, express and implied, including
warranties or conditions of title and non-infringement, and
implied warranties or conditions of merchantability and fitness
for a particular purpose;
ii) effectively excludes on behalf of all other Contributors all
liability for damages, including direct, indirect, special,
incidental and consequential damages, such as lost profits;
iii) does not attempt to limit or alter the recipients' rights
in the Source Code under section 3.2; and
iv) requires any subsequent distribution of the Program by any
party to be under a license that satisfies the requirements
of this section 3.
3.2 When the Program is Distributed as Source Code:
a) it must be made available under this Agreement, or if the
Program (i) is combined with other material in a separate file or
files made available under a Secondary License, and (ii) the initial
Contributor attached to the Source Code the notice described in
Exhibit A of this Agreement, then the Program may be made available
under the terms of such Secondary Licenses, and
b) a copy of this Agreement must be included with each copy of
the Program.
3.3 Contributors may not remove or alter any copyright, patent,
trademark, attribution notices, disclaimers of warranty, or limitations
of liability ("notices") contained within the Program from any copy of
the Program which they Distribute, provided that Contributors may add
their own appropriate notices.
4. COMMERCIAL DISTRIBUTION
Commercial distributors of software may accept certain responsibilities
with respect to end users, business partners and the like. While this
license is intended to facilitate the commercial use of the Program,
the Contributor who includes the Program in a commercial product
offering should do so in a manner which does not create potential
liability for other Contributors. Therefore, if a Contributor includes
the Program in a commercial product offering, such Contributor
("Commercial Contributor") hereby agrees to defend and indemnify every
other Contributor ("Indemnified Contributor") against any losses,
damages and costs (collectively "Losses") arising from claims, lawsuits
and other legal actions brought by a third party against the Indemnified
Contributor to the extent caused by the acts or omissions of such
Commercial Contributor in connection with its distribution of the Program
in a commercial product offering. The obligations in this section do not
apply to any claims or Losses relating to any actual or alleged
intellectual property infringement. In order to qualify, an Indemnified
Contributor must: a) promptly notify the Commercial Contributor in
writing of such claim, and b) allow the Commercial Contributor to control,
and cooperate with the Commercial Contributor in, the defense and any
related settlement negotiations. The Indemnified Contributor may
participate in any such claim at its own expense.
For example, a Contributor might include the Program in a commercial
product offering, Product X. That Contributor is then a Commercial
Contributor. If that Commercial Contributor then makes performance
claims, or offers warranties related to Product X, those performance
claims and warranties are such Commercial Contributor's responsibility
alone. Under this section, the Commercial Contributor would have to
defend claims against the other Contributors related to those performance
claims and warranties, and if a court requires any other Contributor to
pay any damages as a result, the Commercial Contributor must pay
those damages.
5. NO WARRANTY
EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, AND TO THE EXTENT
PERMITTED BY APPLICABLE LAW, THE PROGRAM IS PROVIDED ON AN "AS IS"
BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, EITHER EXPRESS OR
IMPLIED INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OR CONDITIONS OF
TITLE, NON-INFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR
PURPOSE. Each Recipient is solely responsible for determining the
appropriateness of using and distributing the Program and assumes all
risks associated with its exercise of rights under this Agreement,
including but not limited to the risks and costs of program errors,
compliance with applicable laws, damage to or loss of data, programs
or equipment, and unavailability or interruption of operations.
6. DISCLAIMER OF LIABILITY
EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, AND TO THE EXTENT
PERMITTED BY APPLICABLE LAW, NEITHER RECIPIENT NOR ANY CONTRIBUTORS
SHALL HAVE ANY LIABILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL,
EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING WITHOUT LIMITATION LOST
PROFITS), HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN
CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE)
ARISING IN ANY WAY OUT OF THE USE OR DISTRIBUTION OF THE PROGRAM OR THE
EXERCISE OF ANY RIGHTS GRANTED HEREUNDER, EVEN IF ADVISED OF THE
POSSIBILITY OF SUCH DAMAGES.
7. GENERAL
If any provision of this Agreement is invalid or unenforceable under
applicable law, it shall not affect the validity or enforceability of
the remainder of the terms of this Agreement, and without further
action by the parties hereto, such provision shall be reformed to the
minimum extent necessary to make such provision valid and enforceable.
If Recipient institutes patent litigation against any entity
(including a cross-claim or counterclaim in a lawsuit) alleging that the
Program itself (excluding combinations of the Program with other software
or hardware) infringes such Recipient's patent(s), then such Recipient's
rights granted under Section 2(b) shall terminate as of the date such
litigation is filed.
All Recipient's rights under this Agreement shall terminate if it
fails to comply with any of the material terms or conditions of this
Agreement and does not cure such failure in a reasonable period of
time after becoming aware of such noncompliance. If all Recipient's
rights under this Agreement terminate, Recipient agrees to cease use
and distribution of the Program as soon as reasonably practicable.
However, Recipient's obligations under this Agreement and any licenses
granted by Recipient relating to the Program shall continue and survive.
Everyone is permitted to copy and distribute copies of this Agreement,
but in order to avoid inconsistency the Agreement is copyrighted and
may only be modified in the following manner. The Agreement Steward
reserves the right to publish new versions (including revisions) of
this Agreement from time to time. No one other than the Agreement
Steward has the right to modify this Agreement. The Eclipse Foundation
is the initial Agreement Steward. The Eclipse Foundation may assign the
responsibility to serve as the Agreement Steward to a suitable separate
entity. Each new version of the Agreement will be given a distinguishing
version number. The Program (including Contributions) may always be
Distributed subject to the version of the Agreement under which it was
received. In addition, after a new version of the Agreement is published,
Contributor may elect to Distribute the Program (including its
Contributions) under the new version.
Except as expressly stated in Sections 2(a) and 2(b) above, Recipient
receives no rights or licenses to the intellectual property of any
Contributor under this Agreement, whether expressly, by implication,
estoppel or otherwise. All rights in the Program not expressly granted
under this Agreement are reserved. Nothing in this Agreement is intended
to be enforceable by any entity that is not a Contributor or Recipient.
No third-party beneficiary rights are created under this Agreement.
Exhibit A - Form of Secondary Licenses Notice
"This Source Code may also be made available under the following
Secondary Licenses when the conditions for such availability set forth
in the Eclipse Public License, v. 2.0 are satisfied: {name license(s),
version(s), and exceptions or additional permissions here}."
Simply including a copy of this Agreement, including this Exhibit A
is not sufficient to license the Source Code under Secondary Licenses.
If it is not possible or desirable to put the notice in a particular
file, then You may include the notice in a location (such as a LICENSE
file in a relevant directory) where a recipient would be likely to
look for such a notice.
You may add additional accurate notices of copyright ownership.
VERIFICATION
Verification is intended to assist the Chocolatey moderators and community
in verifying that this package's contents are trustworthy.
Weasis can be downloaded from the page
https://nroduit.github.io/en/getting-started/
by selecting the correct build for your operating system.
Direct download:
Version : 4.0.3
x86 URL : https://github.com/nroduit/Weasis/releases/download/v3.6.2/Weasis-3.6.2-x86.msi
x86 SHA256 : D11D3A170B987DD5D939092D0EDEBB9DC74FC2E22F4980F9F91FEBE299020823
x64 URL : https://github.com/nroduit/Weasis/releases/download/v4.0.3/Weasis-4.0.3-x86-64.msi
x64 SHA256 : 679BB2BF3ED1A773FFD5887DA24D4575E4ACBD919BC814438461B1BACCCB4B4B
md5: 675695E78B72F9D3EB6940659681E112 | sha1: 3FFF9976737168CBD04FB97D2B20D1EF1927F14A | sha256: 679BB2BF3ED1A773FFD5887DA24D4575E4ACBD919BC814438461B1BACCCB4B4B | sha512: A52AE4C18517C204A98FABED0CE994E0DD86D55A8256B87F770A33D636A423392007FAB7481B1A5AA4873089CD3DC24A484B2923C0EF3A5E00314BD098EEF1A0
Log in or click on link to see number of positives.
- weasis.4.0.3.nupkg (7367ae67f64b) - ## / 51
- Weasis-4.0.3-x86-64.msi (679bb2bf3ed1) - ## / 54
In cases where actual malware is found, the packages are subject to removal. Software sometimes has false positives. Moderators do not necessarily validate the safety of the underlying software, only that a package retrieves software from the official distribution point and/or validate embedded software against official distribution point (where distribution rights allow redistribution).
Chocolatey Pro provides runtime protection from possible malware.
Add to Builder | Version | Downloads | Last Updated | Status |
---|---|---|---|---|
Weasis Medical Viewer 4.5.1 | 1383 | Monday, September 23, 2024 | Approved | |
Weasis Medical Viewer 4.5.0 | 6142 | Monday, August 19, 2024 | Approved | |
Weasis Medical Viewer 4.4.0 | 43668 | Wednesday, May 8, 2024 | Approved | |
Weasis Medical Viewer 4.3.0 | 27440 | Thursday, February 22, 2024 | Approved | |
Weasis Medical Viewer 4.2.1 | 34512 | Monday, November 13, 2023 | Approved | |
Weasis Medical Viewer 4.2.0 | 26990 | Friday, August 25, 2023 | Approved | |
Weasis Medical Viewer 4.1.2 | 35599 | Friday, June 16, 2023 | Approved | |
Weasis Medical Viewer 4.1.1 | 4821 | Wednesday, May 31, 2023 | Approved | |
Weasis Medical Viewer 4.1.0 | 4824 | Sunday, May 14, 2023 | Approved | |
Weasis Medical Viewer 4.0.3 | 3134 | Saturday, December 3, 2022 | Approved | |
Weasis Medical Viewer 4.0.2 | 1679 | Saturday, August 6, 2022 | Approved | |
Weasis Medical Viewer 4.0.1 | 1038 | Friday, June 24, 2022 | Approved | |
Weasis Medical Viewer 4.0.0-rc | 101 | Monday, May 2, 2022 | Approved | |
Weasis Medical Viewer 3.8.1 | 1353 | Tuesday, February 15, 2022 | Approved | |
Weasis Medical Viewer 3.8.0 | 812 | Wednesday, December 29, 2021 | Approved | |
Weasis Medical Viewer 3.7.1 | 915 | Saturday, June 12, 2021 | Approved | |
Weasis Medical Viewer 3.7.0 | 492 | Sunday, February 14, 2021 | Approved | |
Weasis Medical Viewer 3.6.2 | 519 | Sunday, August 30, 2020 | Approved | |
Weasis Medical Viewer 3.6.1 | 196 | Sunday, July 19, 2020 | Approved | |
Weasis Medical Viewer 3.6.0 | 276 | Sunday, March 8, 2020 | Approved | |
Weasis Medical Viewer 3.5.4 | 255 | Sunday, December 29, 2019 | Approved |
© 2009-2019 Weasis Team
This package has no dependencies.
Ground Rules:
- This discussion is only about Weasis Medical Viewer and the Weasis Medical Viewer package. If you have feedback for Chocolatey, please contact the Google Group.
- This discussion will carry over multiple versions. If you have a comment about a particular version, please note that in your comments.
- The maintainers of this Chocolatey Package will be notified about new comments that are posted to this Disqus thread, however, it is NOT a guarantee that you will get a response. If you do not hear back from the maintainers after posting a message below, please follow up by using the link on the left side of this page or follow this link to contact maintainers. If you still hear nothing back, please follow the package triage process.
- Tell us what you love about the package or Weasis Medical Viewer, or tell us what needs improvement.
- Share your experiences with the package, or extra configuration or gotchas that you've found.
- If you use a url, the comment will be flagged for moderation until you've been whitelisted. Disqus moderated comments are approved on a weekly schedule if not sooner. It could take between 1-5 days for your comment to show up.